Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Net Asset Value(s)

8 Nov 2006 15:08

Aberdeen Growth Opps VCT PLC08 November 2006 ABERDEEN GROWTH OPPORTUNITIES VCT PLC Portfolio Update The Directors are pleased to announce that, following recent gains made on therealisations of investments in Travel Class, Vibration Technology and BondAviation Solutions, Aberdeen Growth Opportunities VCT has now made a significantgain on the sale of its investment in Styles & Wood Holdings. On 13 October 2006, the Company sold its investment in Vibration Technology forproceeds of £339,196, an increase of £189,194 on the Company's previousvaluation and cost of the investment. On 17 October 2006, the Company sold itsinvestment in Bond Aviation Solutions Limited for proceeds of £507,359, anincrease of £87,362 on the Company's previous valuation of the investment,representing a gain of £207,359 on the cost of investment. On 7 November 2006, Styles & Wood Holdings PLC listed on the London StockExchange. As part of the flotation process, the Company realised its investmentin Styles & Wood Holdings Limited for proceeds of £801,809, which represent anincrease of £601,809 over the Company's previous valuation of the investment,and over the cost of the investment. As these investments were made before the C Ordinary share issue, they were madeonly on behalf of the Ordinary share portfolio. The Net Asset Value per COrdinary share as at 31 October 2006 was 95.2p compared to 95.3p at 31 May 2006. In isolation, the increases over previous valuations made on the sales of BondAviation Solutions, Vibration Technology and Styles & Wood indicate an increaseof 9.0p per share in the Net Asset Value of the Ordinary shares. When takentogether with other less significant movements in the valuation of the rest ofthe portfolio, the effect is to increase the Net Asset Value from 96.1p perOrdinary share as at 31 May 2006 to 104.2p per Ordinary share as at 31 October2006. Since the valuation at 31 May 2006 the Net Asset Value per Ordinary sharehas therefore increased by 8.4%. Issued on behalf of the BoardAberdeen Asset Management PLC, Secretary8 November 2006 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.